21 CFR 526.363
§ 526.363 Cephapirin benzathine.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 526.363, § 526.363 Cephapirin benzathine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87663
- Permanent ID
ys:prov:87663@1- SHA-256
0d1c9cdbd8e61d4d3e6ccdf56482d0e3d8c3241bb040053aec521b292afbacf5
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each single-dose, 10-milliliter syringe contains 300 milligrams cephapirin activity (as cephapirin benzathine).
(b) Sponsor. See No. 000010 in § 510.600(c) of this chapter.
(c) Related tolerances. See § 556.115 of this chapter.
(d) Conditions of use in dry cows—(1) Amount. Infuse the contents of one syringe (300 mg cephapirin activity) into each quarter following last milking, but no later than 30 days before calving.
(2) Indications for use. For the treatment of mastitis caused by susceptible strains of Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant strains.
(3) Limitations. For use in dry cows only. Not to be used within 30 days of calving. Milk from treated cows must not be used for food during the first 72 hours after calving. Animals infused with this product must not be slaughtered for food until 42 days after the latest infusion. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.